Canadian cannabis company Canopy Growth (NASDAQ: CGC) saw its shares rise 22.4% so far this week, according to data from S&P Global Intelligence. Canopy's shares got a ride when Tilray, another cannabis company, said it had received approval to sell its medical marijuana in Poland. While the news only applies to Tilray, positive news for one Canadian marijuana company often affects the shares of others, as Tilray, Aurora Cannabis, and Canopy all saw big gains on Wednesday.
Tilray Brands, Inc. (TLRY) closed at $4.03 in the latest trading session, marking a -0.62% move from the prior day.
Canadian cannabis company Tilray Brands (NASDAQ: TLRY) was quite the stock market riser Wednesday morning, ascending by nearly 8% at one point in early trading. Tilray happily announced early Wednesday that its medical marijuana unit, Tilray Medical, has won approval from the government of Poland to sell its therapeutic weed in the Central European country. As it tends to have higher margins despite a far more limited customer base, medical marijuana has been a priority for the Canadian cannabis company.